• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳酸菌对人体免疫系统影响的当前概念]

[The current concepts of the influence of lactobacilli on the immune system of the human body].

作者信息

Kostiuk O P, Chernyshova L I, Volokha A P

出版信息

Fiziol Zh (1994). 1997;43(3-4):106-15.

PMID:9303793
Abstract

The review summarizes experimental and clinical data about the influence of Lactobacillus on the immune system. A conclusion is made that the effect of Lactobacillus is a multifactor process. After entering the intestinal tract live microorganisms or biologically active substances produced by them may activate specific and nonspecific systems of microorganism protection. Experimental and clinical data about the action of Lactobacillus as adjuvants to the humoral immune response are presented. The mechanisms of anticancerogenic action of Lactobacillus and their cell wall components are analyzed in detail. The prospects for the use of Lactobacillus as probiotics in medicine are considered. The conclusion about positive value of the multifactor action of these microorganisms on the human immune system is made, since no negative effects are evoked by the discussed mechanisms of specific effect of Lactobacillus. This opens wide possibilities for the development of application schemes of probiotics from lactobacillus for the stimulation of several functions of the immune system, creation a new forms of antitumor drugs and combination of them with oral vaccines for improving their immunogenicity.

摘要

本综述总结了关于乳酸杆菌对免疫系统影响的实验和临床数据。得出的结论是,乳酸杆菌的作用是一个多因素过程。活的微生物或它们产生的生物活性物质进入肠道后,可能会激活微生物保护的特异性和非特异性系统。文中介绍了乳酸杆菌作为体液免疫反应佐剂作用的实验和临床数据。详细分析了乳酸杆菌及其细胞壁成分的抗癌作用机制。探讨了将乳酸杆菌用作医学益生菌的前景。得出了关于这些微生物对人类免疫系统多因素作用的积极价值的结论,因为所讨论的乳酸杆菌特异性作用机制未引发负面影响。这为开发来自乳酸杆菌的益生菌应用方案以刺激免疫系统的多种功能、创造新的抗肿瘤药物形式以及将它们与口服疫苗联合使用以提高其免疫原性开辟了广阔的可能性。

相似文献

1
[The current concepts of the influence of lactobacilli on the immune system of the human body].[乳酸菌对人体免疫系统影响的当前概念]
Fiziol Zh (1994). 1997;43(3-4):106-15.
2
[The current concepts of the mechanisms of the therapeutic-prophylactic action of probiotics from bacteria in the genus Bacillus].[芽孢杆菌属细菌来源益生菌治疗预防作用机制的当前概念]
Mikrobiol Z. 1993 Jun-Aug;55(4):92-112.
3
Interactions between the microbiota and the intestinal mucosa.微生物群与肠黏膜之间的相互作用。
Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S60-4. doi: 10.1038/sj.ejcn.1601489.
4
Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.益生菌:在过敏性疾病中的应用:营养、过敏、黏膜免疫学与肠道微生物群(NAMI)研究小组报告
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S91-6. doi: 10.1097/MCG.0b013e3181639a98.
5
Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.乳酸菌在小鼠阴道内给药的效果:通过局部施用选定菌株评估副作用和局部免疫反应。
Methods Mol Biol. 2004;268:401-10. doi: 10.1385/1-59259-766-1:401.
6
Lactic acid bacteria and their effect on the immune system.乳酸菌及其对免疫系统的影响。
Curr Issues Intest Microbiol. 2001 Mar;2(1):27-42.
7
The role of the intestinal microflora for the development of the immune system in early childhood.肠道微生物群在儿童早期免疫系统发育中的作用。
Eur J Nutr. 2002 Nov;41 Suppl 1:I32-7. doi: 10.1007/s00394-002-1105-4.
8
Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.口服开菲尔糖乳杆菌产生的胞外多糖对肠道黏膜免疫的影响。
Cytokine. 2006 Dec;36(5-6):254-60. doi: 10.1016/j.cyto.2007.01.003. Epub 2007 Mar 23.
9
Probiotics and the skin.益生菌与皮肤
Clin Dermatol. 2008 Jan-Feb;26(1):4-11. doi: 10.1016/j.clindermatol.2007.10.008.
10
Prophylactic and therapeutic uses of probiotics: a review.益生菌的预防和治疗用途:综述
J Am Diet Assoc. 2001 Feb;101(2):229-38; quiz 239-41. doi: 10.1016/S0002-8223(01)00060-8.